• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Johnson & Johnson touts antibody response for COVID-19 booster 8 months after original...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Aug 25, 2021 at 12:32: PM
via Shortly after the U.S. telegraphed its booster plan for Pfizer and Moderna’s mRNA-based COVID-19 vaccines, Johnson & Johnson has rolled out trial results showing a follow-up dose of its vaccine boosts recipients' antibody responses.

article source
 

<



Similar threads

cafead
Johnson &amp; Johnson adds $1.1 billion to proposed talc settlement
Replies
0
Views
14
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Targeting AZ&#039;s Tagrisso, Johnson &amp; Johnson&#039;s Rybrevant combo wins key FDA nod in first-line lung cancer
Replies
0
Views
23
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson boosts full-year outlook on strong Q2 sales numbers
Replies
0
Views
32
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Johnson &amp; Johnson proposes $505M settlement with bankrupt talc miners
Replies
0
Views
55
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
How Pfizer, Bristol Myers Squibb and Johnson &amp; Johnson Are Confronting Patent Cliffs
Replies
0
Views
51
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote